1. Home
  2. VERI vs CTXR Comparison

VERI vs CTXR Comparison

Compare VERI & CTXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VERI
  • CTXR
  • Stock Information
  • Founded
  • VERI 2014
  • CTXR 2007
  • Country
  • VERI United States
  • CTXR United States
  • Employees
  • VERI N/A
  • CTXR N/A
  • Industry
  • VERI EDP Services
  • CTXR Biotechnology: Pharmaceutical Preparations
  • Sector
  • VERI Technology
  • CTXR Health Care
  • Exchange
  • VERI Nasdaq
  • CTXR Nasdaq
  • Market Cap
  • VERI 90.7M
  • CTXR 84.9M
  • IPO Year
  • VERI 2017
  • CTXR N/A
  • Fundamental
  • Price
  • VERI $2.30
  • CTXR $2.60
  • Analyst Decision
  • VERI Hold
  • CTXR Buy
  • Analyst Count
  • VERI 1
  • CTXR 2
  • Target Price
  • VERI $2.25
  • CTXR $100.00
  • AVG Volume (30 Days)
  • VERI 856.6K
  • CTXR 551.8K
  • Earning Date
  • VERI 11-12-2024
  • CTXR 02-12-2025
  • Dividend Yield
  • VERI N/A
  • CTXR N/A
  • EPS Growth
  • VERI N/A
  • CTXR N/A
  • EPS
  • VERI N/A
  • CTXR N/A
  • Revenue
  • VERI $124,881,000.00
  • CTXR N/A
  • Revenue This Year
  • VERI $10.27
  • CTXR N/A
  • Revenue Next Year
  • VERI $2.47
  • CTXR N/A
  • P/E Ratio
  • VERI N/A
  • CTXR N/A
  • Revenue Growth
  • VERI 6.94
  • CTXR N/A
  • 52 Week Low
  • VERI $1.48
  • CTXR $2.44
  • 52 Week High
  • VERI $7.76
  • CTXR $26.75
  • Technical
  • Relative Strength Index (RSI)
  • VERI 36.35
  • CTXR 29.24
  • Support Level
  • VERI $2.13
  • CTXR $3.15
  • Resistance Level
  • VERI $2.67
  • CTXR $2.85
  • Average True Range (ATR)
  • VERI 0.21
  • CTXR 0.34
  • MACD
  • VERI -0.01
  • CTXR 0.16
  • Stochastic Oscillator
  • VERI 22.97
  • CTXR 11.43

About VERI Veritone Inc.

Veritone Inc is a provider of artificial intelligence (AI) computing solutions and services. It generates revenue through the delivery of its Software Products and Services which consists of revenues generated from Commercial Enterprise and Government and Regulated Industries customers using the company's aiWARE platform and hiring solutions, any related support and maintenance services, and any related professional services associated with the deployment and/or implementation of such solutions, Managed Services which consist of revenues generated from Commercial Enterprise customers using company's content licensing services, advertising agency, influencer management and related services. It has a presence in the United States, the United Kingdom, France, Australia, Israel and India.

About CTXR Citius Pharmaceuticals Inc.

Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. It is currently advancing four proprietary product candidates: LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma . Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections; Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries; Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids; NoveCite, a mesenchymal stem cell therapy for the treatment of acute respiratory distress syndrome.

Share on Social Networks: